Riskpilot← Back to searchSign inGet full accessSafe Implant Technology ApS
APSActiveCVR 38969153Hyldvej 1AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20172 employeeshttps://safeimplant.tech
Revenue 2024
DKK -58K
-70% vs 2023
EBITDA margin
1250.0%
-272% vs 2023
Equity ratio
-72.0%
Financial strength
Net profit 2024
DKK -725K
-272% vs 2023
| Revenue | DKK -58K | -70% |
| EBITDA | DKK -725K | -272% |
| Net profit | DKK -725K | -272% |
| Total assets | DKK 1,2M | -22% |
| Equity | DKK -892K | -432% |
| Employees | 2 | — |
Legal name
Safe Implant Technology ApS
CVR number
38969153
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25. september 2017
Share capital
DKK 50.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af selskabets direktør og et bestyrelsesmedlem
Company purpose
Selskabets formål er at udøve virksomhed med forskning og eksperimentel udvikling indenfor bioteknologi
Address
Hyldvej 1A
Email
info@safeimplant.tech
Website
https://safeimplant.tech
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | -3 | -3 | -3 | -7 | -6 | -195 | -58 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -667 |
| EBITDA | -3 | -3 | -3 | -7 | -6 | -195 | -725 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -3 | -3 | -3 | -7 | -6 | -195 | -725 |
| Net financials | 0 | 0 | 0 | -0 | -0 | 0 | 1 |
| Profit before tax | -3 | -3 | -3 | -7 | -7 | -195 | -725 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -3 | -3 | -3 | -7 | -7 | -195 | -725 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 128 | 393 | 393 | 711 | 924 | 1.584 | 1.239 |
| Equity | 47 | 44 | 41 | 34 | 27 | -168 | -892 |
| Long-term debt | 81 | 0 | 0 | 0 | 877 | 1.728 | 2.091 |
| Short-term debt | 0 | 349 | 352 | 677 | 20 | 24 | 41 |
| Total debt | 81 | 349 | 352 | 677 | 897 | 1.752 | 2.132 |
EBITDA margin
-72528600.0%
This company
15.8%
Market median
-459041872% vs market
20182024
Equity ratio
-72.0%
This company
38.2%
Market median
-288% vs market
20182024
Return on equity
-72451100.0%
This company
18.4%
Market median
-393756078% vs market
20182024
Net profit margin
-72451100.0%
This company
8.1%
Market median
-894458125% vs market
20182024
Asset turnover
-0.05×
This company
1.12×
Market median
-104% vs market
20182024
Debt / equity
2.39×
This company
0.62×
Market median
-285% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-09-25 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HN Management | Management | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Devopharma ApS | Company | 66.7% | 66.7% | 2017 |
BERLOCK ApS | Company | 15.0% | 15.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BERLOCK HOLDING ApS
Safe Implant Technology ApS Board members of Safe Implant Technology ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Nakskov | Management | 0 companies |
| Lone Damgaard Horup | Board of Directors | 0 companies |
| Gorm Danscher | Board of Directors | 0 companies |
| Søren Luplau-Pagh | Chairman | 0 companies |